Kprx stock price.

Oct 4, 2023 · A stock’s beta measures how closely tied its price movements have been to the performance of the overall market. Compare KPRX’s historical performance against its industry peers and the ...

Kprx stock price. Things To Know About Kprx stock price.

Find the latest Cognizant Technology Solutions Corporation (CTSH) stock quote, history, news and other vital information to help you with your stock trading and investing.Stock Prediction for the Price of One Kiora Pharmaceuticals Share in Oct 2025. In Oct 2025 analysts predict a share price of $0.71. An increase of 23.05% compared to today's share price.The Price to Sales ratio or P/S is calculated as price divided by sales. After the P/E ratio, it's one of the most common valuation metrics. If the P/S ratio is 1, that means you're paying $1 for ...KPRX’s Market Performance. The stock of Kiora Pharmaceuticals Inc (KPRX) has seen a 11.98% increase in the past week, with a 9.98% rise in the past month, and a 19.87% gain in the past quarter. The volatility ratio for the week is 4.03%, and the volatility levels for the past 30 days are at 5.80% for KPRX. The simple moving average for the ...

Price Analysis: The pricing strategy adopted by Kiora Pharmaceuticals, Inc. ... Stock Exchanges. AMEX · NASDAQ · NYSE. Recent Posts. Recent Posts. Mastering ...Kiora Pharmaceuticals is a clinical-stage specialty pharmaceutical company that develops and commercializes therapies for the treatment of ophthalmic diseases. …

For comparison, the analyst consensus price prediction for CVNA stock is $40.83 per share. ... (KPRX) Stock Down 7% Today? Why Is Sigma Additive Solutions (SASI) Stock Down 40% Today?Largest borrow rate increases among liquid names October 31, 2023TipRanks. Get Digital World Acquisition Corp (DWAC:NASDAQ) real-time stock quotes, news, price and financial information from CNBC.

What this means: InvestorsObserver gives Kiora Pharmaceuticals Inc. (KPRX) an overall rank of 50, which is below average. Kiora Pharmaceuticals Inc. is in the bottom half of stocks based on the fundamental outlook for the stock and an analysis of the stock's chart. A rank of 50 means that 50% of stocks appear more favorable to our system.A. The stock price for Altamira Therapeutics ( NASDAQ: CYTO) is $ 0.29 last updated November 22, 2023, 4:59 PM PST. Q.Nov 10, 2023 · On Friday, Kiora Pharmaceuticals Inc (KPRX:NAQ) closed at 0.6335, 37.06% above the 52 week low of 0.4622 set on Sep 05, 2023. Data delayed at least 15 minutes, as of Nov 10 2023 20:59 GMT. Latest Kiora Pharmaceuticals Inc (KPRX:NAQ) share price with interactive charts, historical prices, comparative analysis, forecasts, business profile and more. Nowadays finding high-quality stock photos for personal or commercial use is very simple. You just need to search the photo using a few descriptive words and let Google do the rest of the work.

Kiora Pharmaceuticals saw a increase in short interest in November. As of November 15th, there was short interest totaling 539,900 shares, an increase of 67.3% from the previous total of 322,700 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that ...

Salt Lake City, Utah--(Newsfile Corp. - September 26, 2022) - Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX) ("Kiora" or the "Company") announced that its stockholders authorized a reverse stock split ...

Kiora Pharmaceuticals, Inc. (Kiora) is a clinical development-stage company focusing on novel therapeutics for the treatment of orphan retinal diseases with high unmet need. Publicly traded on the NASDAQ under KPRX, our mission is to help patients improve their ocular health and restore vision. Learn more about our companyNov 27, 2023 · Stock Price Forecast. According to 3 stock analysts, the average 12-month stock price forecast for KPRX stock stock is $41.5, which predicts an increase of 7,117.39%. The lowest target is $2.00 and the highest is $119. On average, analysts rate KPRX stock stock as a strong buy. Kiora Pharmaceuticals Inc. stocks price quote with latest real-time prices, charts, financials, latest news, technical analysis and opinions. ... KPRX Stock Quotes ...Find the latest GigaCloud Technology Inc. (GCT) stock quote, history, news and other vital information to help you with your stock trading and investing.1.37%. $3.03B. META | Complete Meta Platforms Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.SONX | Complete Sonendo Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.

Kiora Pharmaceuticals, Inc. (Kiora) is a clinical development-stage company focusing on novel therapeutics for the treatment of orphan retinal diseases with high unmet need. Publicly traded on the NASDAQ under KPRX, our mission is to help patients improve their ocular health and restore vision. Learn more about our company Mission Statement of Kiora Pharmaceuticals, Inc. (KPRX) General Summary of Kiora Pharmaceuticals, Inc. (KPRX) Kiora Pharmaceuticals, Inc. (KPRX) is a renowned pharmaceutical company known for its innovative approach to drug development and its commitment to improving the lives of patients. Founded in 1998, the company has since …Mar 23, 2023 ... KPRX is down -$0.30 from the previous closing price of $3.63 on volume of 65,404 shares. Over the past year the S&P 500 is down -11.54% while ...According to 3 analysts, the average rating for KPRX stock is "Strong Buy." The 12-month stock price forecast is $41.5, which is an increase of 8,122.71% from the latest price. Price TargetGet the latest KPRX (KPRX) stock quote, charts, news and other financial information to help you make more informed trading and investment decisions. KPRX is a biopharmaceutical company that develops and commercializes products for neurological disorders.

KPRX is a biotechnology company that develops and commercializes therapies for ophthalmic diseases. The stock price, quote, news, and analysis of KPRX …

The Kiora Pharmaceuticals Inc (KPRX) stock price forecast for the next 12 months is generally positive, with an average analyst price target of $28.38, representing a +5,060% increase from the current price of $0.55. The highest analyst price target is $35.44, and the lowest is $21.32.What's Happening with KPRX Stock Today. Kiora Pharmaceuticals Inc (KPRX) stock has fallen -3.85% while the S&P 500 is lower by -0.23% as of 11:42 AM on Friday, May 19. KPRX is lower by -$0.08 from the previous closing price of $2.08 on volume of 43,119 shares. Over the past year the S&P 500 is higher by 7.37% while KPRX is lower by -88.18%.The Kiora Pharmaceuticals Inc (KPRX) stock price forecast for the next 12 months is generally positive, with an average analyst price target of $28.38, representing a +5,060% increase from the current price of $0.55. The highest analyst price target is $35.44, and the lowest is $21.32.The post Beyond the Big Banks: Lesser-Known Canadian Stocks Offering Attractive Yields appeared first on The Motley Fool Canada. Find the latest ATCO Ltd. (ACO-X.TO) stock quote, history, news and other vital information to …Jun 2, 2023 · Encinitas, California-- (Newsfile Corp. - June 2, 2023) - Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX) ("Kiora" or the "Company") today announced the pricing of an underwritten public offering for ... Agile Therapeutics, Inc. (NASDAQ:AGRX) Q3 2023 Earnings Call Transcript November 9, 2023 Agile Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.27, expectations were $-1.58.View the full Dow Jones Industrial Average (DJIA) index overview including the latest stock market news, data and trading information.SALT LAKE CITY, Nov. 08, 2021 (GLOBE NEWSWIRE) -- Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX), (“Kiora” or the “Company”) is the new name of EyeGate... Day High / …Get the latest Boeing Co (BA) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.

The average twelve-month price prediction for Catalyst Pharmaceuticals is $24.75 with a high price target of $27.00 and a low price target of $24.00. Learn more on CPRX's analyst rating history. Do Wall Street analysts like Catalyst Pharmaceuticals more than its competitors? Analysts like Catalyst Pharmaceuticals more than other Medical companies.

Get the latest Kiora Pharmaceuticals, Inc. (KPRX) stock news and headlines to help you in your trading and investing decisions.

Find the latest Novo Integrated Sciences, Inc. (NVOS) stock quote, history, news and other vital information to help you with your stock trading and investing.2019: The company went public and began trading on the NASDAQ stock exchange under the ticker symbol KPRX, allowing it to raise additional funds to support the ...Stocktwits provides real-time stock, crypto & international market data to keep you up-to-date. Find top news headlines, discover your next trade idea, share & gain insights from traders and investors from around the world, build a watchlist, buy US stocks, & create and manage your portfolio.It's typically categorized as a valuation metric and is most often quoted as Cash Flow per Share and as a Price to Cash flow ratio. In this case, it's the cash flow growth that's being looked at ...View the latest Kiora Pharmaceuticals Inc. (KPRX) stock price, news, historical charts, analyst ratings and financial information from WSJ.Kiora Pharmaceuticals Stock Chart and Share Price Forecast, Short-Term "KPRX" Stock Prediction for Next Days and Weeks Walletinvestor.com Kiora Pharmaceuticals Inc (KPRX) Forecast Chart, Long-Term Predictions for Next Months and Year: 2023, 2024The reverse stock split caused the price of KPRX stock to jump from its prior value of 18 cents per share when markets closed on Monday. This saw the stock opening on Tuesday at a price of $6.18.Find the latest Phillips 66 (PSX) stock quote, history, news and other vital information to help you with your stock trading and investing.The Kiora Pharmaceuticals Inc (KPRX) stock price forecast for the next 12 months is generally positive, with an average analyst price target of $28.38, representing a +5,060% increase from the current price of $0.55. The highest analyst price target is $35.44, and the lowest is $21.32. Nov 30, 2023 · The latest price target for Kiora Pharmaceuticals ( NASDAQ: KPRX) was reported by HC Wainwright & Co. on Monday, November 13, 2023. The analyst firm set a price target for 3.50 expecting KPRX to ... Find the latest TOP Financial Group Limited (TOP) stock quote, history, news and other vital information to help you with your stock trading and investing.

Find the latest Prudential Financial, Inc. (PRU) stock quote, history, news and other vital information to help you with your stock trading and investing.Tonix Pharmaceuticals' stock was trading at $2.4363 on January 1st, 2023. Since then, TNXP shares have decreased by 80.1% and is now trading at $0.4855. View the best growth stocks for 2023 here.Oct 16, 2023 ... %. Search stocks, ETFs and Commodities. Instrument Name Kiora Pharmaceuticals Inc. Instrument Symbol (KPRX-Q). Instrument Exchange NASDAQ. Add ...Kiora Pharmaceuticals Inc. historical stock charts and prices, analyst ratings, financials, and today’s real-time KPRX stock price.Instagram:https://instagram. apline bankbest fixed rate annuityhow to trade in forexdgro expense ratio Top 20. HK Stock Quick Quote provides information including Free HK shares Real-time Quote, HK Shares Technical Chart, Related A Shares Quote, ADR, HK Shares PE Ratio, HK Shares Yield, HK Shares ... 1964 kennedy half dollar value todayday trading under 25k These Healthcare stocks are trading higher: -Genprex Inc (GNPX) stock is trading at $2.91, a gain of $1.6, or 122.14%, on high volume. Genprex Inc gets a Sentiment Score of Bear best international etfs 2023 Get the latest Eli Lilly And Co (LLY) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.0.20%. $7.78B. Acorda Therapeutics Inc. -1.31%. $11.98M. CPRX | Complete Catalyst Pharmaceuticals Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial ...